Agenus Inc news

   Watch this stock
Showing stories 1 - 10 of about 28   

Articles published

AGEN 3.00 -0.08 (-2.60%)
price chart
Agenus Inc - A Potential New Play On Ebola
Shares of Agenus Inc (NASDAQ: AGEN) have moved to the upside in Monday's trade as the company is being mentioned as a potential play on Ebola.
Related articles »  
Rising Stocks: Agenus Inc(NASDAQ:AGEN), RadioShack Corporation(NYSE ...
Agenus Inc(NASDAQ:AGEN) currently has a market capitalization of $184.9 million and 62.68 million tradeable shares. The stock currently has a bid price of $3.00 x 200 and an offer price of $3.18 x 600.
Related articles »  
Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss?
Agenus posted positive surprises in three of the last four quarters with an average beat of 35.47%. However, things are not looking good since the second quarter.
Related articles »  
Fast Moving Stocks: American Airlines Group Inc. (NASDAQ:AAL), Vical ...
Biotech companies and the town of Lexington split the cost for shuttle buses that carry workers from Alewife Station to biotech research parks.
Some biotechs decamp for Lexington, seeking room to grow
Garo Armen, chief executive of Agenus Inc., said the town offers better amenities, such as more restaurants and a nicer hotel nearby, than it did in 2004, when his company signed a 30-year lease there.
Global Therapeutics Market shows a tremendous growth
Companies profiled in the report are Dendreon Corp, Agenus Inc., Bavarian Nordic A/S, Novartis International AG, GlaxoSmithKline plc, Argos Therapeutics Inc., AFFiRiS AG, CEL-SCI Corp, Celldex Therapeutics Inc., GlobeImmune Inc., Cytos Biotechnology ...
Audience Inc. (ADNC) Drops 5.15% on October 10
Agenus Inc along with its subsidiaries is a biopharmaceutical company, which is developing and commercializing technologies to treat cancers and degenerative disorders.
Related articles »  
NASA declares to Award its Huge Contract to Boeing (NYSE:BA) and SpaceX
NASA was scheduled to award a contract of lucrative commercial squad program; three companies were known officially to be the frontrunners for the contract.
Related articles »  
5 Companies That Could Develop An Enterovirus Treatment
When it comes to the search for Ebola treatments, names like BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Chimerix Inc (NASDAQ: CMRX), Sarepta Therapeutics Inc (NASDAQ: SRPT) and Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) have cropped up ...
Related articles »  
Are AgenusInc(AGEN) and Cytokinetics, Inc.(CYTK) Poised For Success In The ...
AgenusInc(NASDAQ:AGEN) is a Massachusetts-based biopharmaceutical company that develops immune-oncology candidates. The company's products include checkpoint modulators, adjuvants, and heat shock protein vaccines.
Related articles »